VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
XLVHealth Care Select Sector SPDR Fund
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksXLVRevenue History

XLV logoHealth Care Select Sector SPDR Fund (XLV) Revenue History

Annual and quarterly revenue from Infinity to present

TTM Revenue$0
YoY Growth—
$0
Revenue CAGR
3Y—
→
5Y—
→
10Y—
Best Fiscal Year$0 (0)
Best Quarter$0 ()

XLV Revenue Over Time

XLV Revenue Growth History

XLV Revenue Analysis (Infinity–-Infinity)

Current Revenue & Growth

As of June 12, 2026, Health Care Select Sector SPDR Fund (XLV) generated trailing twelve-month (TTM) revenue of $0.

Historical Growth Trajectory

XLV's historical revenue data shows various trends over time.

XLV Historical Revenue Data

1–0 of 0 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin

What if you invested $1,000 in XLV back in Infinity?

Total return with dividends reinvested · -Infinity+ years of data

Calculate Returns

How much would $100/month in XLV be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is XLV Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

How does XLV stack up against peers?

Compare business quality, growth, and profitability against top sector peers.

Compare Now

XLV — Frequently Asked Questions

Quick answers to the most common questions about buying XLV stock.

Is XLV's revenue growth accelerating or slowing?

XLV TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is XLV's revenue history from Infinity to 2026?

Health Care Select Sector SPDR Fund (XLV) revenue history spans Infinity to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is XLV's long-term revenue growth rate (CAGR)?

Health Care Select Sector SPDR Fund's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for XLV.

Why does XLV's quarterly revenue fluctuate?

XLV quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Health Care Select Sector SPDR Fund's revenue data from Infinity to 2026 shows full historical quarterly detail on this page.

How is XLV's revenue distributed by segment?

XLV reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does XLV's revenue compare to industry peers?

Health Care Select Sector SPDR Fund (XLV) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.